Understanding Mesangial Pathobiology in AL-Amyloidosis and Monoclonal Ig Light Chain Deposition Disease - Kidney International Reports
Cardiac amyloidosis: An update on diagnosis and treatment | Cleveland Clinic Journal of Medicine
Systemic Immunoglobulin Light Chain Amyloidosis–Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome - Mayo Clinic Proceedings
Development of anti-amyloid fibril-reactive monoclonal antibodies for treatment of AL amyloidosis | Lentzsch Lab
Future Developments in Light Chain Amyloidosis Management - The American Journal of Medicine
Red Flag Presentations of Immunoglobulin Light Chain Amyloidosis in Patients With Multiple Myeloma - The ASCO Post
Immunoglobulin light chain amyloid aggregation - Chemical Communications (RSC Publishing)
Update on treatment of light chain amyloidosis | Haematologica
Light chain amyloidosis: Where are the light chains from and how they play their pathogenic role? - ScienceDirect
Amyloidosis | Saint Luke's Health System
PLOS ONE: Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis | Circulation Research
Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis - Journal of Biological Chemistry
Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications | Experimental Hematology & Oncology | Full Text
Light-Chain (AL) Amyloidosis: Diagnosis and Treatment | American Society of Nephrology
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis - Journal of Biological Chemistry
AL Primary Amyloidosis | Stanford Health Care
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis